Burkholderia cepacia (Palleroni and Holmes) Yabuuchi et al. (ATCC® 700070)

Strain Designations: K61-3  /  Type Strain: no  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Strain Designations K61-3
Isolation
Patient with cystic fibrosis, Canada
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain no
Antibiotic Resistance
Chloramphenicol-, ciprofloxacin-, and trimethoprim-resistant
Medium ATCC® Medium 3: Nutrient agar or nutrient broth
Growth Conditions
Temperature: 30°C
Atmosphere: Aerobic
Name of Depositor JL Burns
Special Collection NCRR Contract
Chain of Custody
ATCC <-- JL Burns <-- D Woods <-- C Prober
Isolation
Patient with cystic fibrosis, Canada
References

Burns JL, et al. Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability. Antimicrob. Agents Chemother. 33: 136-141, 1989. PubMed: 2719457

Burns JL, et al. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob. Agents Chemother. 40: 307-313, 1996. PubMed: 8834871

Cross References

Nucleotide (GenBank) : U38944 cDNA for outer membrane protein, opcM

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation